| |
| |
|
| Insider
Information: |
Link Max |
| Relationship: |
Director |
| City: |
8044 Zurich Switzerland |
| State: |
|
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
9 |
|
| Direct
Shares |
1,228,236 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$12,471,550 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
1,228,236 |
|
|
| Total
Value |
$12,471,550 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Juniper Pharmaceuticals Inc |
JNP |
Director |
2003-08-08 |
23,000 |
2003-08-08 |
0 |
Premium* |
|
|
Cti Biopharma Corporation |
CTIC |
Director |
2005-09-30 |
73,572 |
2003-09-25 |
0 |
Premium* |
|
|
Windtree Therapeutics Inc |
WINT |
Director |
2007-03-09 |
166,821 |
2003-09-25 |
0 |
Premium* |
|
|
PDL Biopharma Inc |
PDLI |
Director |
2005-11-02 |
159,916 |
2003-09-25 |
0 |
Premium* |
|
|
Celsion Corp |
CLSN |
Director |
2012-12-10 |
380,385 |
2003-12-22 |
0 |
Premium* |
|
|
Alexion Pharmaceuticals Inc |
ALXN |
Director |
2014-02-28 |
59,469 |
2004-04-06 |
0 |
Premium* |
|
|
Human Genome Sciences Inc |
HGSI |
Director |
2008-04-11 |
27,699 |
2007-07-10 |
0 |
Premium* |
|
|
Ladrx |
LADX |
Director |
2012-02-23 |
260,305 |
2007-04-27 |
0 |
Premium* |
|
|
Sintx Technologies Ord Shs |
SINT |
Director |
2014-08-12 |
77,069 |
|
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
25 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| ALXN |
Alexion Pharmaceuticals I... |
Director |
– • – |
2014-02-03 |
4 |
S |
$154.02 |
$6,206,219 |
D/D |
(40,000) |
58,574 |
0 |
- |
|
| ALXN |
Alexion Pharmaceuticals I... |
Director |
– • – |
2012-08-14 |
4 |
S |
$103.76 |
$10,355,245 |
D/D |
(99,673) |
89,781 |
0 |
- |
|
| ALXN |
Alexion Pharmaceuticals I... |
Director |
– • – |
2011-02-22 |
4 |
S |
$95.00 |
$4,499,865 |
D/D |
(47,367) |
92,898 |
0 |
- |
|
| ALXN |
Alexion Pharmaceuticals I... |
Director |
– • – |
2011-02-28 |
4 |
S |
$95.00 |
$4,525,515 |
D/D |
(47,637) |
92,988 |
0 |
- |
|
| ALXN |
Alexion Pharmaceuticals I... |
Director |
– • – |
2010-02-18 |
4 |
S |
$49.34 |
$1,973,600 |
D/D |
(40,000) |
122,540 |
0 |
- |
|
| ALXN |
Alexion Pharmaceuticals I... |
Director |
– • – |
2010-01-19 |
4 |
OE |
$42.06 |
$168,240 |
D/D |
4,000 |
158,575 |
0 |
- |
|
| ALXN |
Alexion Pharmaceuticals I... |
Director |
– • – |
2010-05-18 |
4 |
OE |
$40.25 |
$603,750 |
D/D |
15,000 |
137,540 |
0 |
- |
|
| ALXN |
Alexion Pharmaceuticals I... |
Director |
– • – |
2009-04-27 |
4 |
S |
$33.94 |
$1,357,600 |
D/D |
(40,000) |
134,575 |
0 |
- |
|
| ALXN |
Alexion Pharmaceuticals I... |
Director |
– • – |
2009-09-10 |
4 |
OE |
$32.25 |
$645,000 |
D/D |
20,000 |
154,575 |
0 |
- |
|
| ALXN |
Alexion Pharmaceuticals I... |
Director |
– • – |
2006-08-10 |
4 |
S |
$31.60 |
$523,928 |
D/D |
(16,580) |
45,577 |
|
- |
|
| ALXN |
Alexion Pharmaceuticals I... |
Director |
– • – |
2005-10-10 |
4 |
B |
$26.62 |
$401,562 |
D/D |
15,000 |
57,657 |
2.39 |
- |
|
| ALXN |
Alexion Pharmaceuticals I... |
Director |
– • – |
2005-11-01 |
4 |
B |
$21.76 |
$54,400 |
D/D |
2,500 |
60,157 |
2.39 |
- |
|
| ALXN |
Alexion Pharmaceuticals I... |
officerTitle |
– • – |
2006-01-09 |
4 |
A |
$20.72 |
$41,440 |
D/D |
2,000 |
62,157 |
|
- |
|
| ALXN |
Alexion Pharmaceuticals I... |
Director |
– • – |
2004-12-29 |
4 |
B |
$15.58 |
$81,575 |
D/D |
5,000 |
42,657 |
2.39 |
- |
|
| PDLI |
PDL Biopharma Inc |
Director |
– • – |
2004-04-07 |
4 |
OE |
$13.55 |
$313,360 |
D/D |
20,000 |
100,000 |
|
- |
|
| PDLI |
PDL Biopharma Inc |
Director |
– • – |
2005-11-02 |
4 |
OE |
$13.55 |
$1,008,904 |
D/D |
59,916 |
159,916 |
|
- |
|
| CTIC |
Cti Biopharma Corporation |
Director |
– • – |
2003-09-25 |
4 |
OE |
$11.81 |
$177,150 |
D/D |
15,000 |
53,572 |
|
- |
|
| HGSI |
Human Genome Sciences Inc |
Director |
– • – |
2008-01-11 |
4 |
A |
$11.62 |
$9,621 |
D/D |
828 |
26,719 |
0 |
- |
|
| ALXN |
Alexion Pharmaceuticals I... |
Director |
– • – |
2012-08-24 |
4 |
OE |
$10.84 |
$1,154,000 |
D/D |
80,000 |
169,781 |
0 |
- |
|
| ALXN |
Alexion Pharmaceuticals I... |
Director |
– • – |
2004-04-06 |
4 |
B |
$10.74 |
$169,914 |
D/D |
9,501 |
37,667 |
2.39 |
- |
|
| ALXN |
Alexion Pharmaceuticals I... |
Director |
– • – |
2007-06-11 |
4 |
OE |
$10.74 |
$792,383 |
D/D |
35,166 |
82,743 |
0 |
- |
|
| HGSI |
Human Genome Sciences Inc |
Director |
– • – |
2007-10-10 |
4 |
A |
$10.02 |
$4,749 |
D/D |
474 |
25,891 |
0 |
- |
|
| HGSI |
Human Genome Sciences Inc |
Director |
– • – |
2007-07-10 |
4 |
A |
$8.99 |
$3,749 |
D/D |
417 |
25,417 |
0 |
- |
|
| CLSN |
Celsion Corp |
Director |
– • – |
2012-12-10 |
4 |
B |
$7.60 |
$106,400 |
D/D |
14,000 |
380,385 |
2.39 |
- |
|
| CTIC |
Cti Biopharma Corporation |
Director |
– • – |
2004-12-30 |
4 |
OE |
$6.63 |
$99,450 |
D/D |
15,000 |
68,572 |
|
- |
|
25 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
